Safety and immunogenicity of combined or associated administration of PRP-T vaccine with diphtheria, tetanus and pertussis vaccine in Thai children

Journal of Tropical Pediatrics

Volumn 47, Issue 1, 2001, Pages 24-29

  Lolekha, S ^a   Hiranchote, A ^b   Simasathien, S ^c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Nakorn Pathom Hospital   (Thailand)

^c PRAMONGKUTKLAO HOSPITAL   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DT COQ; HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

ADVERSE DRUG REACTION; AGE; ANALYSIS; ANTIBODY TITER; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CONJUGATION; DRUG SAFETY; DRUG TOLERABILITY; FEVER; HUMAN; IMMUNOGENICITY; INFANT; PAIN; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; THAILAND; VACCINATION;

ANTIBODY FORMATION; CONSUMER PRODUCT SAFETY; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; HAEMOPHILUS VACCINES; HUMANS; INFANT; THAILAND; VACCINES, COMBINED;

EID: 0035112945     PISSN: 01426338     EISSN: None     Source Type: Journal    
DOI: 10.1093/tropej/47.1.24     Document Type: Article

References (21)

1. World Health Organization Global programme for vaccines and immunization
2. Current situation of Hemophilus influenzae b diseases in Thailand
3. Practical considerations for Haemophilus influenzae type b immunization programs
4. Haemophilus influenzae: Then and now
5. Progress toward elimination of Haemophilus influenzae type b disease among infants and children - United States, 1987-1995
6. Safety and immunogenicity of Haemophilus type b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis vaccine in young infants
7. A quantitative immunochemical measure of the primary interaction between I·BSA and antibody
8. Quantitative measurement of 'natural' and immunisation-induced Haemophilus influenzae type b capsular polysaccharide anti-bodies
9. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b
10. Immunoenzymatic assay of antidiphtheria toxin antibodies in human serum
11. A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralisation test in mice as a method for the estimation of tetanus antitoxin in human sera
12. Serological response to Bordetella pertussis
13. The clinical and immunologic response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus two, four and six months of age
14. Enhanced antibody response in Venezuelan infants immunized with Haeomphilus influenzae type b-tetanus toxoid conjugate vaccine
15. Antibody persistence and Haemophilus influenzae type b carriage after infant immunization with PRP-T
16. Impact of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine on responses to concurrently administered diphtheria-tetanus-pertussis vaccine
17. Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serologic responses to diphtheria, tetanus or diphtheria-tetanus-pertussis at two, four and six months of age
18. Antibody responses and symptoms after DTP and either tetanus or diphtheria Haemophilus influenzae type B conjugate vaccines given for primary immunization by separate or mixed injection
19. No adverse impact on protection against pertussis from combined administration of Haemophilus influenzae type b conjugate and diphtheria-tetanus toxoid-pertussis vaccines in the same syringe
20. Large scale postlicensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: Practicality and effectiveness in preventing invasive Haemophilus influenzae type b infections
21. The impact of conjugate vaccine on carriage of Haemophilus influenzae type b